American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: http://www.sciepub.com/journal/ajcp Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
Go
American Journal of Cancer Prevention. 2016, 4(4), 64-69
DOI: 10.12691/ajcp-4-4-4
Open AccessCase Report

Surgical Treatment of Huge Primary Retroperitoneal Tumor: A Report of 14 Cases

Zheng-jun Cheng1, Qian Cheng2, Jian-ping Gong2, Chan Qiu3 and Da-xing Li1,

1Department of General Surgery, The Second People's Hospital of Jiulongpo District, Chong Qing, China

2Department of Hepatobiliary, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

3Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Pub. Date: January 05, 2017

Cite this paper:
Zheng-jun Cheng, Qian Cheng, Jian-ping Gong, Chan Qiu and Da-xing Li. Surgical Treatment of Huge Primary Retroperitoneal Tumor: A Report of 14 Cases. American Journal of Cancer Prevention. 2016; 4(4):64-69. doi: 10.12691/ajcp-4-4-4

Abstract

Objective: To summarize the surgical therapy for huge retroperitoneal tumor. Methods: Retrospective analysis was carried out to study the surgical therapy on 14 patients with huge retroperitoneal tumor. Results: Complete resection in eight cases, partial resection in two cases, combined evisceration in three cases, one biopsy and six cases recurred after surgery. Conclusion: Operative skills and the management during perioperative period are important for the treatment of huge retroperitoneal tumor.

Keywords:
huge retroperitoneal tumor surgical therapy perioperative management

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Virseda Rodríguez JA, Donate Moreno MJ, Pastor Navarro H, et al. Primary retroperitoneal tumors: review of our 10-year case series. Arch Esp Urol 2010; 63: 13-22.
 
[2]  Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007; 67: 158-163.
 
[3]  Tseng WW, Madewell JE, Wei W, et al. Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection? Ann Surg Oncol 2014; 21: 2136-2143.
 
[4]  Krikelis D, Judson I. Role of chemotherapy in the management of soft tissue sarcomas. Expert Rev Anticancer Ther 2010; 10: 249-260.
 
[5]  An JY, Heo JS, Noh JH, et al. Primary malignant retroperitoneal tumors: analysis of a single institutional experience. Eur J Surg Oncol 2007; 33: 376-382.
 
[6]  Pisters PWT, O’Sullivan B. Retroperitoneal sarcomas: combined modality treatment approaches. Curr Opin Oncol 2002; 14: 400-405.
 
[7]  Youssef E, Fontanesi J, Mott M, et al. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys 2002; 54: 514-519.
 
[8]  Pirayesh A, Chee Y, Helliwell TR, et al. The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2001; 27: 491-497.
 
[9]  Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100: 2448-2455.
 
[10]  Erzen D, Sencar M, Novak J. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana. J Surg Oncol 2005; 91: 1-9.
 
[11]  Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol Off J Am Soc Clin Oncol 2000; 18: 1637-1643.
 
[12]  Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg Chic Ill 1960 2003; 138: 248-251.